United Therapeutics Corporation and Miromatrix Medical Inc. announced October 30th a definitive agreement for United Therapeutics to acquire Miromatrix. Miromatrix is a life sciences company focused on the development of bioengineered organs composed of human cells. United Therapeutics is a biotechnology company with six FDA-approved therapies to address rare, life-threatening conditions, and a pipeline that [...]The post United Therapeutics Buys Miromatrix for $91M to Expand Organ Manufacturing appeared first on Healthcare Weekly.
Miromatrix is a Minnesota-based biotechnology company that develops and commercializes bioengineered transplantable kidneys and livers for organ transplantation.